Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Clinical Pharmacy and Therapeutics
|
October 18, 2002
Development of a Canadian family medicine pharmacy practice experience programme
A M Whelan
DICP : the Annals of Pharmacotherapy
|
June 1, 1990
Doxepin in smoking cessation
A M Whelan, S K Davis
DICP : the Annals of Pharmacotherapy
|
June 1, 1991
Optimizing drug delivery from metered-dose inhalers
A M Whelan, N W Hahn
Canadian Family Physician Medecin De Famille Canadien
|
March 1, 1994
Pharmacy services in family medicine residencies. Survey of clinics associated with Canadian residency programs
A M Whelan, F Burge, K Munroe
Journal of Clinical Pharmacy and Therapeutics
|
September 14, 2010
Case report. Efficacy of Hoodia for weight loss: is there evidence to support the efficacy claims?
A M Whelan, T M Jurgens, V Szeto
Journal of Clinical Pharmacy and Therapeutics
|
April 7, 2005
The impact of socioeconomic and demographic factors on the utilization of smoking cessation medications in patients hospitalized with cardiovascular disease in Nova Scotia, Canada
A M Whelan, C A Cooke, I S Sketris
The Journal of Family Practice
|
February 1, 1992
The effect of aspirin on niacin-induced cutaneous reactions
A M Whelan, S O Price, S F Fowler, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
September 28, 2001
Physician characteristics in relation to cardiovascular drugs commonly prescribed for hypertension in Nova Scotia
F Burge, G Kephart, G Flowerdew, et al.
Genes, Brain, and Behavior
|
January 25, 2012
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome
C A Hoeffer, E Sanchez, R J Hagerman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Clinical Pharmacy and Therapeutics
|
October 18, 2002
Development of a Canadian family medicine pharmacy practice experience programme
A M Whelan
DICP : the Annals of Pharmacotherapy
|
June 1, 1990
Doxepin in smoking cessation
A M Whelan, S K Davis
DICP : the Annals of Pharmacotherapy
|
June 1, 1991
Optimizing drug delivery from metered-dose inhalers
A M Whelan, N W Hahn
Canadian Family Physician Medecin De Famille Canadien
|
March 1, 1994
Pharmacy services in family medicine residencies. Survey of clinics associated with Canadian residency programs
A M Whelan, F Burge, K Munroe
Journal of Clinical Pharmacy and Therapeutics
|
September 14, 2010
Case report. Efficacy of Hoodia for weight loss: is there evidence to support the efficacy claims?
A M Whelan, T M Jurgens, V Szeto
Journal of Clinical Pharmacy and Therapeutics
|
April 7, 2005
The impact of socioeconomic and demographic factors on the utilization of smoking cessation medications in patients hospitalized with cardiovascular disease in Nova Scotia, Canada
A M Whelan, C A Cooke, I S Sketris
The Journal of Family Practice
|
February 1, 1992
The effect of aspirin on niacin-induced cutaneous reactions
A M Whelan, S O Price, S F Fowler, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
September 28, 2001
Physician characteristics in relation to cardiovascular drugs commonly prescribed for hypertension in Nova Scotia
F Burge, G Kephart, G Flowerdew, et al.
Genes, Brain, and Behavior
|
January 25, 2012
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome
C A Hoeffer, E Sanchez, R J Hagerman, et al.
Page
of 1